<?xml version="1.0" encoding="utf-8"?>
<iati-activities xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xsd="http://www.w3.org/2001/XMLSchema" version="2.03" generated-datetime="2026-02-14T15:44:46.6367068+01:00" linked-data-default="http://data-service.theglobalfund.org/api">
	<iati-activity last-updated-datetime="2026-02-14T00:00:00+01:00" xml:lang="en" default-currency="USD" humanitarian="false" hierarchy="1">
		<iati-identifier>47045-BLR-C-UNDP-1</iati-identifier>
		<reporting-org ref="47045" type="30" secondary-reporter="false">
			<narrative xml:lang="en">The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
		</reporting-org>
		<title>
			<narrative xml:lang="en">Strengthening of HIV and tuberculosis (“TB”) national systems of prevention, treatment, care and support in the Republic of Belarus - Phase 2 - Belarus (01-Nov-2022-31-Dec-2024)</narrative>
		</title>
		<description type="1">
			<narrative xml:lang="en">Belarus, TB/HIV, United Nations Development Programme (UNDP Belarus)This program has the following goals: To support Belarus in implementing the updated national TB and HIV strategies for the period of 2021-2025 in order to decrease the burden and suffering caused by HIV infection and TB, to improve enabling environment and systems that are people-centered for effective and sustainable response to HIV and TB challenges in the country.. The objectives of this program are: Close the gap in achieving 95-95-95 targets: increase early HIV detection, rapid initiation of ART and improve quality of care.  Reduce new HIV transmissions.  Improve access to early diagnostics, including WHO-recommended rapid diagnostic methods.  Improve treatment outcomes through expanding access to WHO-recommended MDR TB treatment regimens and adherence support.  Expand coverage with TB preventive treatment in all key groups.  Zero discrimination and remove human rights and gender barriers.  Leverage health and community system resources to sustain delivery of high coverage, quality HIV and TB services</narrative>
		</description>
		<participating-org ref="47045" type="30" role="1">
			<narrative xml:lang="en">The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
		</participating-org>
		<participating-org ref="47045" type="30" role="1">
			<narrative xml:lang="en">The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
		</participating-org>
		<participating-org type="40" role="2">
			<narrative xml:lang="en">United Nations Development Programme</narrative>
		</participating-org>
		<participating-org type="40" role="3">
			<narrative xml:lang="en">United Nations Development Programme</narrative>
		</participating-org>
		<participating-org type="40" role="4">
			<narrative xml:lang="en">United Nations Development Programme</narrative>
		</participating-org>
		<other-identifier ref="BLR-C-UNDPP01" type="A1">
			<owner-org ref="47045">
				<narrative xml:lang="en">The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
			</owner-org>
		</other-identifier>
		<activity-status code="4" />
		<activity-date type="1" iso-date="2022-11-01" />
		<activity-date type="2" iso-date="2022-11-01" />
		<activity-date type="3" iso-date="2024-12-31" />
		<contact-info type="1">
			<organisation>
				<narrative xml:lang="en">The Global Fund to Fight AIDS Tuberculosis and Malaria</narrative>
			</organisation>
			<department>
				<narrative xml:lang="en">Communications</narrative>
			</department>
			<person-name>
				<narrative xml:lang="en">Web Team</narrative>
			</person-name>
			<job-title>
				<narrative xml:lang="en"> </narrative>
			</job-title>
			<telephone>+41 58 791 1700</telephone>
			<email>website@theglobalfund.org</email>
			<website>https://www.theglobalfund.org</website>
			<mailing-address>
				<narrative xml:lang="en">The Global Fund to Fight AIDS, Tuberculosis and Malaria, Global Health Campus, Chemin du Pommier 40, 1218 Grand-Saconnex, Geneva, Switzerland</narrative>
			</mailing-address>
		</contact-info>
		<contact-info type="2">
			<organisation>
				<narrative xml:lang="en">The Global Fund to Fight AIDS Tuberculosis and Malaria</narrative>
			</organisation>
			<department>
				<narrative xml:lang="en">Grant Management Division</narrative>
			</department>
			<person-name>
				<narrative xml:lang="en">Valeria, GRISHECHKINA</narrative>
			</person-name>
			<job-title>
				<narrative xml:lang="en">Fund Portfolio Manager</narrative>
			</job-title>
			<telephone>+41 58 791 1700</telephone>
			<email>valeria.grishechkina@theglobalfund.org</email>
			<website>https://www.theglobalfund.org</website>
			<mailing-address>
				<narrative xml:lang="en">The Global Fund to Fight AIDS, Tuberculosis and Malaria, Global Health Campus, Chemin du Pommier 40, 1218 Grand-Saconnex, Geneva, Switzerland</narrative>
			</mailing-address>
		</contact-info>
		<contact-info type="4">
			<organisation>
				<narrative xml:lang="en">The Global Fund to Fight AIDS Tuberculosis and Malaria</narrative>
			</organisation>
			<department>
				<narrative xml:lang="en">Communications</narrative>
			</department>
			<person-name>
				<narrative xml:lang="en">Web Team</narrative>
			</person-name>
			<telephone>+41 58 791 1700</telephone>
			<email>website@theglobalfund.org</email>
			<website>https://www.theglobalfund.org</website>
			<mailing-address>
				<narrative xml:lang="en">The Global Fund to Fight AIDS, Tuberculosis and Malaria, Global Health Campus, Chemin du Pommier 40, 1218 Grand-Saconnex, Geneva, Switzerland</narrative>
			</mailing-address>
		</contact-info>
		<activity-scope code="4" />
		<recipient-country code="BY" percentage="100">
			<narrative xml:lang="en">Belarus</narrative>
		</recipient-country>
		<sector vocabulary="1" code="13040" percentage="36">
			<narrative xml:lang="en">HIV</narrative>
		</sector>
		<sector vocabulary="1" code="12110" percentage="49">
			<narrative xml:lang="en">Multicomponent</narrative>
		</sector>
		<sector vocabulary="1" code="12110" percentage="0">
			<narrative xml:lang="en">RSSH</narrative>
		</sector>
		<sector vocabulary="1" code="12263" percentage="15">
			<narrative xml:lang="en">Tuberculosis</narrative>
		</sector>
		<country-budget-items vocabulary="4">
			<budget-item code="5.1.1" percentage="4">
				<description>
					<narrative xml:lang="en">HIV -&gt; Differentiated HIV Testing Services -&gt; Community-based testing</narrative>
				</description>
			</budget-item>
			<budget-item code="5.1.1" percentage="0">
				<description>
					<narrative xml:lang="en">HIV -&gt; Differentiated HIV Testing Services -&gt; Facility-based testing</narrative>
				</description>
			</budget-item>
			<budget-item code="5.1.1" percentage="0">
				<description>
					<narrative xml:lang="en">HIV -&gt; Differentiated HIV Testing Services -&gt; Self-testing</narrative>
				</description>
			</budget-item>
			<budget-item code="5.1.1" percentage="17">
				<description>
					<narrative xml:lang="en">HIV -&gt; Prevention -&gt; Behavior change interventions</narrative>
				</description>
			</budget-item>
			<budget-item code="5.1.1" percentage="1">
				<description>
					<narrative xml:lang="en">HIV -&gt; Prevention -&gt; Condom and lubricant programing</narrative>
				</description>
			</budget-item>
			<budget-item code="5.1.1" percentage="2">
				<description>
					<narrative xml:lang="en">HIV -&gt; Prevention -&gt; Needle and syringe programs</narrative>
				</description>
			</budget-item>
			<budget-item code="5.1.1" percentage="2">
				<description>
					<narrative xml:lang="en">HIV -&gt; Prevention -&gt; Opioid substitution therapy and other medically assisted drug dependence treatment</narrative>
				</description>
			</budget-item>
			<budget-item code="5.1.1" percentage="0">
				<description>
					<narrative xml:lang="en">HIV -&gt; Prevention -&gt; Sexual and reproductive health services, including STIs</narrative>
				</description>
			</budget-item>
			<budget-item code="5.1.1" percentage="0">
				<description>
					<narrative xml:lang="en">HIV -&gt; Reducing human rights-related barriers to HIV/TB services -&gt; HIV and HIV/TB-related legal services</narrative>
				</description>
			</budget-item>
			<budget-item code="5.1.1" percentage="0">
				<description>
					<narrative xml:lang="en">HIV -&gt; Reducing human rights-related barriers to HIV/TB services -&gt; Sensitization of law-makers and law-enforcement agents</narrative>
				</description>
			</budget-item>
			<budget-item code="5.1.1" percentage="0">
				<description>
					<narrative xml:lang="en">HIV -&gt; Reducing human rights-related barriers to HIV/TB services -&gt; Stigma and discrimination reduction (HIV/TB)</narrative>
				</description>
			</budget-item>
			<budget-item code="5.1.1" percentage="6">
				<description>
					<narrative xml:lang="en">HIV -&gt; Treatment, care and support -&gt; Counseling and psycho-social support</narrative>
				</description>
			</budget-item>
			<budget-item code="5.1.1" percentage="4">
				<description>
					<narrative xml:lang="en">HIV -&gt; Treatment, care and support -&gt; Differentiated ART service delivery and HIV care</narrative>
				</description>
			</budget-item>
			<budget-item code="5.1.1" percentage="1">
				<description>
					<narrative xml:lang="en">HIV -&gt; Treatment, care and support -&gt; Treatment monitoring - Viral load</narrative>
				</description>
			</budget-item>
			<budget-item code="5.1.1" percentage="16">
				<description>
					<narrative xml:lang="en">Multicomponent -&gt; COVID-19 -&gt; Case management, clinical operations and therapeutics</narrative>
				</description>
			</budget-item>
			<budget-item code="5.1.1" percentage="6">
				<description>
					<narrative xml:lang="en">Multicomponent -&gt; COVID-19 -&gt; COVID diagnostics and testing</narrative>
				</description>
			</budget-item>
			<budget-item code="5.1.1" percentage="0">
				<description>
					<narrative xml:lang="en">Multicomponent -&gt; COVID-19 -&gt; Infection prevention and control, and protection of the health workforce</narrative>
				</description>
			</budget-item>
			<budget-item code="5.1.1" percentage="4">
				<description>
					<narrative xml:lang="en">Multicomponent -&gt; COVID-19 -&gt; Laboratory systems</narrative>
				</description>
			</budget-item>
			<budget-item code="5.1.1" percentage="2">
				<description>
					<narrative xml:lang="en">Multicomponent -&gt; COVID-19 -&gt; Mitigation for HIV programs</narrative>
				</description>
			</budget-item>
			<budget-item code="5.1.1" percentage="0">
				<description>
					<narrative xml:lang="en">Multicomponent -&gt; COVID-19 -&gt; Respond to human rights and gender related barriers to services</narrative>
				</description>
			</budget-item>
			<budget-item code="5.1.1" percentage="21">
				<description>
					<narrative xml:lang="en">Multicomponent -&gt; Program management -&gt; Grant management</narrative>
				</description>
			</budget-item>
			<budget-item code="5.1.1" percentage="0">
				<description>
					<narrative xml:lang="en">RSSH -&gt; RSSH: Community systems strengthening -&gt; Community-based monitoring</narrative>
				</description>
			</budget-item>
			<budget-item code="5.1.1" percentage="0">
				<description>
					<narrative xml:lang="en">RSSH -&gt; RSSH: Community systems strengthening -&gt; Institutional capacity building, planning and leadership development</narrative>
				</description>
			</budget-item>
			<budget-item code="5.1.1" percentage="0">
				<description>
					<narrative xml:lang="en">RSSH -&gt; RSSH: Community systems strengthening -&gt; Social mobilization, building community linkages and coordination</narrative>
				</description>
			</budget-item>
			<budget-item code="5.1.1" percentage="0">
				<description>
					<narrative xml:lang="en">RSSH -&gt; RSSH: Health management information systems and M&amp;E -&gt; Program and data quality</narrative>
				</description>
			</budget-item>
			<budget-item code="5.1.1" percentage="0">
				<description>
					<narrative xml:lang="en">RSSH -&gt; RSSH: Health sector governance and planning -&gt; National health sector strategies and financing</narrative>
				</description>
			</budget-item>
			<budget-item code="5.1.1" percentage="0">
				<description>
					<narrative xml:lang="en">RSSH -&gt; RSSH: Human resources for health, including community health workers -&gt; In-service training (excluding community health workers)</narrative>
				</description>
			</budget-item>
			<budget-item code="5.1.1" percentage="0">
				<description>
					<narrative xml:lang="en">RSSH -&gt; RSSH: Monitoring and evaluation systems -&gt; Surveys</narrative>
				</description>
			</budget-item>
			<budget-item code="5.1.1" percentage="7">
				<description>
					<narrative xml:lang="en">Tuberculosis -&gt; MDR-TB -&gt; Case detection and diagnosis (MDR-TB)</narrative>
				</description>
			</budget-item>
			<budget-item code="5.1.1" percentage="0">
				<description>
					<narrative xml:lang="en">Tuberculosis -&gt; MDR-TB -&gt; Key populations (MDR-TB) - Prisoners</narrative>
				</description>
			</budget-item>
			<budget-item code="5.1.1" percentage="6">
				<description>
					<narrative xml:lang="en">Tuberculosis -&gt; MDR-TB -&gt; Treatment (MDR-TB)</narrative>
				</description>
			</budget-item>
			<budget-item code="5.1.1" percentage="1">
				<description>
					<narrative xml:lang="en">Tuberculosis -&gt; TB care and prevention -&gt; Prevention (TB care and prevention)</narrative>
				</description>
			</budget-item>
			<budget-item code="5.1.1" percentage="0">
				<description>
					<narrative xml:lang="en">Tuberculosis -&gt; TB care and prevention -&gt; Treatment (TB care and prevention)</narrative>
				</description>
			</budget-item>
		</country-budget-items>
		<collaboration-type code="1" />
		<default-flow-type code="10" />
		<default-finance-type code="110" />
		<default-aid-type code="C01" />
		<default-tied-status code="5" />
		<budget type="2" status="2">
			<period-start iso-date="2024-01-01" />
			<period-end iso-date="2024-12-31" />
			<value currency="USD" value-date="2022-11-01">11098934.41</value>
		</budget>
		<budget type="2" status="2">
			<period-start iso-date="2023-01-01" />
			<period-end iso-date="2023-12-31" />
			<value currency="USD" value-date="2022-11-01">8183691.82</value>
		</budget>
		<budget type="2" status="2">
			<period-start iso-date="2025-01-01" />
			<period-end iso-date="2025-12-31" />
			<value currency="USD" value-date="2022-11-01">4041735.35</value>
		</budget>
		<transaction ref="e70f355a-3d97-4f72-810e-0d775dfbe511">
			<transaction-type code="2" />
			<transaction-date iso-date="2025-01-03" />
			<value currency="USD" value-date="2025-01-03">-29036.00</value>
			<description>
				<narrative xml:lang="en">Global Fund Commitment to BLR-C-UNDPP01.</narrative>
			</description>
			<provider-org type="40">
				<narrative xml:lang="en">Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
			</provider-org>
			<receiver-org>
				<narrative xml:lang="en">United Nations Development Programme (UNDP Belarus)</narrative>
			</receiver-org>
			<aid-type code="C01" />
			<tied-status code="5" />
		</transaction>
		<transaction ref="cff9f901-fcc9-486a-b9b3-477110ae9a6c">
			<transaction-type code="2" />
			<transaction-date iso-date="2024-05-06" />
			<value currency="USD" value-date="2024-05-06">-2261860.00</value>
			<description>
				<narrative xml:lang="en">Global Fund Commitment to BLR-C-UNDPP01.</narrative>
			</description>
			<provider-org type="40">
				<narrative xml:lang="en">Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
			</provider-org>
			<receiver-org>
				<narrative xml:lang="en">United Nations Development Programme (UNDP Belarus)</narrative>
			</receiver-org>
			<aid-type code="C01" />
			<tied-status code="5" />
		</transaction>
		<transaction ref="2a316b67-45f0-462e-91ec-4dde613ab048">
			<transaction-type code="2" />
			<transaction-date iso-date="2022-11-29" />
			<value currency="USD" value-date="2022-11-29">20855499.00</value>
			<description>
				<narrative xml:lang="en">Global Fund Commitment to BLR-C-UNDPP01.</narrative>
			</description>
			<provider-org type="40">
				<narrative xml:lang="en">Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
			</provider-org>
			<receiver-org>
				<narrative xml:lang="en">United Nations Development Programme (UNDP Belarus)</narrative>
			</receiver-org>
			<aid-type code="C01" />
			<tied-status code="5" />
		</transaction>
		<transaction ref="3073d803-537f-4cc8-97c4-a1c27fdf3b4e">
			<transaction-type code="2" />
			<transaction-date iso-date="2024-05-06" />
			<value currency="USD" value-date="2024-05-06">4463570.41</value>
			<description>
				<narrative xml:lang="en">Global Fund Commitment to BLR-C-UNDPP01.</narrative>
			</description>
			<provider-org type="40">
				<narrative xml:lang="en">Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
			</provider-org>
			<receiver-org>
				<narrative xml:lang="en">United Nations Development Programme (UNDP Belarus)</narrative>
			</receiver-org>
			<aid-type code="C01" />
			<tied-status code="5" />
		</transaction>
		<transaction ref="f819a47f-d145-4c15-a364-8a3288c0f7ad">
			<transaction-type code="3" />
			<transaction-date iso-date="2023-12-07" />
			<value currency="USD" value-date="2023-12-07">1530006.00</value>
			<description>
				<narrative xml:lang="en">Global Fund disbursement to BLR-C-UNDPP01.</narrative>
			</description>
			<provider-org type="40">
				<narrative xml:lang="en">Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
			</provider-org>
			<receiver-org>
				<narrative xml:lang="en">United Nations Development Programme (UNDP Belarus)</narrative>
			</receiver-org>
			<aid-type code="C01" />
			<tied-status code="5" />
		</transaction>
		<transaction ref="1359baf9-9845-476e-a416-cb800a3f3137">
			<transaction-type code="3" />
			<transaction-date iso-date="2024-06-18" />
			<value currency="USD" value-date="2024-06-18">3035361.85</value>
			<description>
				<narrative xml:lang="en">Global Fund disbursement to BLR-C-UNDPP01.</narrative>
			</description>
			<provider-org type="40">
				<narrative xml:lang="en">Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
			</provider-org>
			<receiver-org>
				<narrative xml:lang="en">United Nations Development Programme (UNDP Belarus)</narrative>
			</receiver-org>
			<aid-type code="C01" />
			<tied-status code="5" />
		</transaction>
		<transaction ref="f74c23c5-2550-485c-819f-7f7a57f8cfec">
			<transaction-type code="3" />
			<transaction-date iso-date="2022-12-13" />
			<value currency="USD" value-date="2022-12-13">4708312.00</value>
			<description>
				<narrative xml:lang="en">Global Fund disbursement to BLR-C-UNDPP01.</narrative>
			</description>
			<provider-org type="40">
				<narrative xml:lang="en">Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
			</provider-org>
			<receiver-org>
				<narrative xml:lang="en">United Nations Development Programme (UNDP Belarus)</narrative>
			</receiver-org>
			<aid-type code="C01" />
			<tied-status code="5" />
		</transaction>
		<transaction ref="f9edff5a-9b84-409b-a843-3847921b23a8">
			<transaction-type code="7" />
			<transaction-date iso-date="2024-12-30" />
			<value currency="USD" value-date="2024-12-30">-29036.00</value>
			<description>
				<narrative xml:lang="en">Global Fund disbursement to BLR-C-UNDPP01.</narrative>
			</description>
			<provider-org>
				<narrative xml:lang="en">United Nations Development Programme (UNDP Belarus)</narrative>
			</provider-org>
			<receiver-org type="40">
				<narrative xml:lang="en">The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
			</receiver-org>
			<aid-type code="C01" />
			<tied-status code="5" />
		</transaction>
		<transaction ref="1970b170-e82c-4eec-9da4-57f7402622c6">
			<transaction-type code="3" />
			<transaction-date iso-date="2023-06-15" />
			<value currency="USD" value-date="2023-06-15">310257.00</value>
			<description>
				<narrative xml:lang="en">Global Fund disbursement to BLR-C-UNDPP01.</narrative>
			</description>
			<provider-org type="40">
				<narrative xml:lang="en">Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
			</provider-org>
			<receiver-org>
				<narrative xml:lang="en">United Nations Development Programme (UNDP Belarus)</narrative>
			</receiver-org>
			<aid-type code="C01" />
			<tied-status code="5" />
		</transaction>
		<transaction ref="4d131ee3-482d-42b2-8119-246720f7faec">
			<transaction-type code="3" />
			<transaction-date iso-date="2023-06-15" />
			<value currency="USD" value-date="2023-06-15">1395199.00</value>
			<description>
				<narrative xml:lang="en">Global Fund disbursement to BLR-C-UNDPP01.</narrative>
			</description>
			<provider-org type="40">
				<narrative xml:lang="en">Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
			</provider-org>
			<receiver-org>
				<narrative xml:lang="en">United Nations Development Programme (UNDP Belarus)</narrative>
			</receiver-org>
			<aid-type code="C01" />
			<tied-status code="5" />
		</transaction>
		<transaction ref="02d6125f-3bc5-4804-b45b-f8133b3815ec">
			<transaction-type code="3" />
			<transaction-date iso-date="2023-01-05" />
			<value currency="USD" value-date="2023-01-05">4495424.00</value>
			<description>
				<narrative xml:lang="en">Global Fund disbursement to BLR-C-UNDPP01.</narrative>
			</description>
			<provider-org type="40">
				<narrative xml:lang="en">Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
			</provider-org>
			<receiver-org>
				<narrative xml:lang="en">United Nations Development Programme (UNDP Belarus)</narrative>
			</receiver-org>
			<aid-type code="C01" />
			<tied-status code="5" />
		</transaction>
		<transaction ref="c8d81210-d6fc-4d99-b90f-ca12431f9696">
			<transaction-type code="3" />
			<transaction-date iso-date="2024-02-01" />
			<value currency="USD" value-date="2024-02-01">2661214.00</value>
			<description>
				<narrative xml:lang="en">Global Fund disbursement to BLR-C-UNDPP01.</narrative>
			</description>
			<provider-org type="40">
				<narrative xml:lang="en">Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
			</provider-org>
			<receiver-org>
				<narrative xml:lang="en">United Nations Development Programme (UNDP Belarus)</narrative>
			</receiver-org>
			<aid-type code="C01" />
			<tied-status code="5" />
		</transaction>
		<transaction ref="509aa530-67b9-4ea9-b22a-7ec556a0d65e">
			<transaction-type code="3" />
			<transaction-date iso-date="2025-04-01" />
			<value currency="USD" value-date="2025-04-01">494544.00</value>
			<description>
				<narrative xml:lang="en">Global Fund disbursement to BLR-C-UNDPP01.</narrative>
			</description>
			<provider-org type="40">
				<narrative xml:lang="en">Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
			</provider-org>
			<receiver-org>
				<narrative xml:lang="en">United Nations Development Programme (UNDP Belarus)</narrative>
			</receiver-org>
			<aid-type code="C01" />
			<tied-status code="5" />
		</transaction>
		<transaction ref="6da5059f-b8e5-4ad3-a49b-2f7eceefe3ac">
			<transaction-type code="3" />
			<transaction-date iso-date="2022-12-13" />
			<value currency="USD" value-date="2022-12-13">508489.00</value>
			<description>
				<narrative xml:lang="en">Global Fund disbursement to BLR-C-UNDPP01.</narrative>
			</description>
			<provider-org type="40">
				<narrative xml:lang="en">Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
			</provider-org>
			<receiver-org>
				<narrative xml:lang="en">United Nations Development Programme (UNDP Belarus)</narrative>
			</receiver-org>
			<aid-type code="C01" />
			<tied-status code="5" />
		</transaction>
		<transaction ref="106451db-1080-47fe-a10f-a2b50a26076f">
			<transaction-type code="3" />
			<transaction-date iso-date="2024-10-01" />
			<value currency="USD" value-date="2024-10-01">1240957.56</value>
			<description>
				<narrative xml:lang="en">Global Fund disbursement to BLR-C-UNDPP01.</narrative>
			</description>
			<provider-org type="40">
				<narrative xml:lang="en">Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
			</provider-org>
			<receiver-org>
				<narrative xml:lang="en">United Nations Development Programme (UNDP Belarus)</narrative>
			</receiver-org>
			<aid-type code="C01" />
			<tied-status code="5" />
		</transaction>
		<transaction ref="4f4f0cee-573c-4e6c-9b73-3ea0e7c13b54">
			<transaction-type code="3" />
			<transaction-date iso-date="2023-01-05" />
			<value currency="USD" value-date="2023-01-05">2490194.00</value>
			<description>
				<narrative xml:lang="en">Global Fund disbursement to BLR-C-UNDPP01.</narrative>
			</description>
			<provider-org type="40">
				<narrative xml:lang="en">Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
			</provider-org>
			<receiver-org>
				<narrative xml:lang="en">United Nations Development Programme (UNDP Belarus)</narrative>
			</receiver-org>
			<aid-type code="C01" />
			<tied-status code="5" />
		</transaction>
		<document-link url="https://data.theglobalfund.org/grant/BLR-C-UNDP" format="text/html">
			<title>
				<narrative xml:lang="en">Grant page on the data portal of the Global Fund.</narrative>
			</title>
			<description>
				<narrative xml:lang="en">An overview of a grant over it's lifetime.</narrative>
			</description>
			<category code="A12" />
			<category code="A02" />
			<category code="A01" />
			<category code="A07" />
			<category code="A05" />
			<category code="A08" />
			<document-date iso-date="2026-02-14" />
		</document-link>
		<document-link url="https://www.theglobalfund.org/media/13342/core_grantregulationsversiontwo_regulations_en.pdf" format="application/pdf">
			<title>
				<narrative xml:lang="en">Grant terms and conditions.</narrative>
			</title>
			<description>
				<narrative xml:lang="en">General terms and conditions which apply to Global Fund grants.</narrative>
			</description>
			<category code="A04" />
			<document-date iso-date="2026-02-14" />
		</document-link>
		<result type="1" aggregation-status="false">
			<title>
				<narrative xml:lang="en">Coverage / Output indicators targets and results for BLR-C-UNDPP01</narrative>
			</title>
			<indicator measure="2" aggregation-status="false">
				<title>
					<narrative xml:lang="en">Percentage of people newly diagnosed with HIV initiated on ART</narrative>
				</title>
				<period>
					<period-start iso-date="2022-11-01" />
					<period-end iso-date="2023-12-31" />
					<target value="91.00" />
					<actual value="83.40" />
				</period>
				<period>
					<period-start iso-date="2022-11-01" />
					<period-end iso-date="2023-12-31" />
					<target value="91.03" />
					<actual value="83.40" />
				</period>
			</indicator>
			<indicator measure="2" aggregation-status="false">
				<title>
					<narrative xml:lang="en">Percentage of people who inject drugs that have received an HIV test during the reporting period and know their results</narrative>
				</title>
				<period>
					<period-start iso-date="2022-11-01" />
					<period-end iso-date="2023-12-31" />
					<target value="47.75" />
					<actual value="42.30" />
				</period>
				<period>
					<period-start iso-date="2022-11-01" />
					<period-end iso-date="2023-12-31" />
					<target value="47.70" />
					<actual value="42.30" />
				</period>
			</indicator>
			<indicator measure="1" aggregation-status="false">
				<title>
					<narrative xml:lang="en">Number of cases with RR-TB and/or MDR-TB that began second-line treatment</narrative>
				</title>
				<period>
					<period-start iso-date="2022-11-01" />
					<period-end iso-date="2023-12-31" />
					<target value="856" />
					<actual value="645" />
				</period>
			</indicator>
			<indicator measure="2" aggregation-status="false">
				<title>
					<narrative xml:lang="en">Percentage of sex workers that have received an HIV test during the reporting period and know their results</narrative>
				</title>
				<period>
					<period-start iso-date="2022-11-01" />
					<period-end iso-date="2023-12-31" />
					<target value="45.80" />
					<actual value="47.70" />
				</period>
				<period>
					<period-start iso-date="2022-11-01" />
					<period-end iso-date="2023-12-31" />
					<target value="45.81" />
					<actual value="47.70" />
				</period>
			</indicator>
			<indicator measure="2" aggregation-status="false">
				<title>
					<narrative xml:lang="en">Percentage of individuals receiving Opioid Substitution Therapy who received treatment for at least 6 months</narrative>
				</title>
				<period>
					<period-start iso-date="2022-11-01" />
					<period-end iso-date="2023-12-31" />
					<target value="64.94" />
					<actual value="58.50" />
				</period>
				<period>
					<period-start iso-date="2022-11-01" />
					<period-end iso-date="2023-12-31" />
					<target value="64.90" />
					<actual value="58.50" />
				</period>
			</indicator>
			<indicator measure="2" aggregation-status="false">
				<title>
					<narrative xml:lang="en">Percentage of sex workers reached with HIV prevention programs - defined package of services</narrative>
				</title>
				<period>
					<period-start iso-date="2022-11-01" />
					<period-end iso-date="2023-12-31" />
					<target value="60.22" />
					<actual value="74.20" />
				</period>
				<period>
					<period-start iso-date="2022-11-01" />
					<period-end iso-date="2023-12-31" />
					<target value="60.20" />
					<actual value="74.20" />
				</period>
			</indicator>
			<indicator measure="2" aggregation-status="false">
				<title>
					<narrative xml:lang="en">Percentage of men who have sex with men that have received an HIV test during the reporting period and know their results</narrative>
				</title>
				<period>
					<period-start iso-date="2022-11-01" />
					<period-end iso-date="2023-12-31" />
					<target value="44.38" />
					<actual value="37.00" />
				</period>
				<period>
					<period-start iso-date="2022-11-01" />
					<period-end iso-date="2023-12-31" />
					<target value="44.40" />
					<actual value="37.00" />
				</period>
			</indicator>
			<indicator measure="2" aggregation-status="false">
				<title>
					<narrative xml:lang="en">Percentage of men who have sex with men reached with HIV prevention programs - defined package of services</narrative>
				</title>
				<period>
					<period-start iso-date="2022-11-01" />
					<period-end iso-date="2023-12-31" />
					<target value="57.90" />
					<actual value="49.60" />
				</period>
				<period>
					<period-start iso-date="2022-11-01" />
					<period-end iso-date="2023-12-31" />
					<target value="57.95" />
					<actual value="49.60" />
				</period>
			</indicator>
			<indicator measure="2" aggregation-status="false">
				<title>
					<narrative xml:lang="en">Percentage of HIV-positive new and relapse TB patients on ART during TB treatment</narrative>
				</title>
				<period>
					<period-start iso-date="2022-11-01" />
					<period-end iso-date="2023-12-31" />
					<target value="94.00" />
					<actual value="92.10" />
				</period>
			</indicator>
			<indicator measure="2" aggregation-status="false">
				<title>
					<narrative xml:lang="en">Percentage of people who inject drugs reached with HIV prevention programs - defined package of services</narrative>
				</title>
				<period>
					<period-start iso-date="2022-11-01" />
					<period-end iso-date="2023-12-31" />
					<target value="75.00" />
					<actual value="80.40" />
				</period>
			</indicator>
			<indicator measure="1" aggregation-status="false">
				<title>
					<narrative xml:lang="en">Number of TB cases with RR-TB and/or MDR-TB notified</narrative>
				</title>
				<period>
					<period-start iso-date="2022-11-01" />
					<period-end iso-date="2023-12-31" />
					<target value="856" />
					<actual value="695" />
				</period>
			</indicator>
			<indicator measure="2" aggregation-status="false">
				<title>
					<narrative xml:lang="en">Percentage of people on ART among all people living with HIV at the end of the reporting period</narrative>
				</title>
				<period>
					<period-start iso-date="2022-11-01" />
					<period-end iso-date="2023-12-31" />
					<target value="81.90" />
					<actual value="81.20" />
				</period>
			</indicator>
			<indicator measure="1" aggregation-status="false">
				<title>
					<narrative xml:lang="en">Number of notified cases of all forms of TB (i.e. bacteriologically confirmed + clinically diagnosed), new and relapse cases</narrative>
				</title>
				<period>
					<period-start iso-date="2022-11-01" />
					<period-end iso-date="2023-12-31" />
					<target value="1300" />
					<actual value="1558" />
				</period>
			</indicator>
		</result>
		<result type="2" aggregation-status="false">
			<title>
				<narrative xml:lang="en">Outcome indicators targets and results for BLR-C-UNDPP01</narrative>
			</title>
			<indicator measure="2" aggregation-status="false">
				<title>
					<narrative xml:lang="en">TB treatment coverage: Percentage of patients with new and relapse TB that were notified and treated among the estimated number of incident TB in the same year (all forms of TB - bacteriologically confirmed plus clinically diagnosed</narrative>
				</title>
				<period>
					<period-start iso-date="2022-11-01" />
					<period-end iso-date="2023-12-31" />
					<target value="80.10" />
					<actual value="64.23" />
				</period>
			</indicator>
			<indicator measure="2" aggregation-status="false">
				<title>
					<narrative xml:lang="en">Percentage of people living with HIV who know their HIV status at the end of the reporting period</narrative>
				</title>
				<period>
					<period-start iso-date="2022-11-01" />
					<period-end iso-date="2023-12-31" />
					<target value="87.50" />
					<actual value="86.89" />
				</period>
			</indicator>
			<indicator measure="2" aggregation-status="false">
				<title>
					<narrative xml:lang="en">Treatment success rate of RR-TB and/or MDR-TB: Percentage of patients with RR and/or MDR-TB successfully treated</narrative>
				</title>
				<period>
					<period-start iso-date="2022-11-01" />
					<period-end iso-date="2023-12-31" />
					<target value="77.00" />
					<actual value="78.73" />
				</period>
			</indicator>
			<indicator measure="1" aggregation-status="false">
				<title>
					<narrative xml:lang="en">Treatment success rate of all forms of TB - bacteriologically confirmed plus clinically diagnosed, new and relapse</narrative>
				</title>
				<period>
					<period-start iso-date="2022-11-01" />
					<period-end iso-date="2023-12-31" />
					<target value="90.00" />
					<actual value="869" />
				</period>
			</indicator>
			<indicator measure="2" aggregation-status="false">
				<title>
					<narrative xml:lang="en">Percentage of people living with HIV and on ART who are virologically suppressed</narrative>
				</title>
				<period>
					<period-start iso-date="2022-11-01" />
					<period-end iso-date="2023-12-31" />
					<target value="91.00" />
					<actual value="88.17" />
				</period>
			</indicator>
		</result>
		<result type="3" aggregation-status="false">
			<title>
				<narrative xml:lang="en">Impact indicators targets and results for BLR-C-UNDPP01</narrative>
			</title>
			<indicator measure="1" aggregation-status="false">
				<title>
					<narrative xml:lang="en">TB mortality rate per 100,000 population</narrative>
				</title>
				<period>
					<period-start iso-date="2022-11-01" />
					<period-end iso-date="2023-12-31" />
					<target value="1.18" />
					<actual value="0.96" />
				</period>
			</indicator>
			<indicator measure="2" aggregation-status="false">
				<title>
					<narrative xml:lang="en">RR-TB and/or MDR-TB prevalence among new TB patients: Proportion of new TB patients with RR-TB and/or MDR-TB</narrative>
				</title>
				<period>
					<period-start iso-date="2022-11-01" />
					<period-end iso-date="2023-12-31" />
					<target value="38.30" />
					<actual value="36.26" />
				</period>
			</indicator>
		</result>
	</iati-activity>
</iati-activities>